150 related articles for article (PubMed ID: 2684408)
1. [Hemofiltration and hemoperfusion performed in series for the purpose of removing beta 2 microglobulin].
Marangoni R; Civardi F; Savino R; Manfredi A; Masi F; Avanzi C; Lino S
Cas Lek Cesk; 1989 Sep; 128(39):1217-20. PubMed ID: 2684408
[TBL] [Abstract][Full Text] [Related]
2. [Changes in the beta 2-microglobulin level during hemodialysis].
Nikitinskaia LP; Stetsiuk EA; Iarmolinskiĭ IS; Barinov AV; Kon'kova TA
Urol Nefrol (Mosk); 1990; (5):29-31. PubMed ID: 2264202
[TBL] [Abstract][Full Text] [Related]
3. Beta 2-microglobulin kinetics during haemofiltration.
Floege J; Wilks M; Shaldon S; Koch KM; Smeby LC
Nephrol Dial Transplant; 1988; 3(6):784-9. PubMed ID: 3147420
[TBL] [Abstract][Full Text] [Related]
4. [The removal of beta 2-microglobulin during continuous and intermittent hemofiltration].
Timokhov VS; Kazakov IV; Toritsina LK; Ametov AS; Semavin IE
Urol Nefrol (Mosk); 1989; (5):47-51. PubMed ID: 2688248
[TBL] [Abstract][Full Text] [Related]
5. [The effect of hemodialysis and hemofiltration on the serum beta-2 microglobulin content of patients kept on chronic hemodialysis regimen (author's transl)].
Prejac M; Mikulicic V; Jeren-Struić B; Kozjak D
Lijec Vjesn; 1980; 102(7-8):386-91. PubMed ID: 6169969
[No Abstract] [Full Text] [Related]
6. Coated charcoal haemoperfusion.
Chang TM
Life Support Syst; 1984; 2(2):99-106. PubMed ID: 6384672
[TBL] [Abstract][Full Text] [Related]
7. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
8. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
[TBL] [Abstract][Full Text] [Related]
9. Improvement of continuous arteriovenous hemofiltration (CAVH) and hemofiltration (HF) efficiency by adding hemoperfusion (HP).
Marangoni R; Civardi F; Masi F; Avanzi C; Savino R; Manfredi A; Cimino R
Biomater Artif Cells Artif Organs; 1990; 18(4):541-8. PubMed ID: 2285819
[TBL] [Abstract][Full Text] [Related]
10. [Developing trends in the active therapy of kidney failure. Hemodialysis--hemofiltration--hemoperfusion].
Klinkmann H; Kolff WJ
Z Gesamte Inn Med; 1978 Jun; 33(11):351-5. PubMed ID: 685330
[TBL] [Abstract][Full Text] [Related]
11. [Beta 2-microglobulin kinetics during hemodialysis with different membranes].
Stetsiuk EA; Siniukhin VN; Danilkov AP; Shpazhnikova NS; Nikolaeva NP; Khamaganova EG
Urol Nefrol (Mosk); 1995; (3):18-20. PubMed ID: 7618215
[TBL] [Abstract][Full Text] [Related]
12. Preliminary report on the efficiency of combined haemodialysis-haemoperfusion treatment in chronic uraemia.
Albertazzi A; Cappelli P; Di Paolo B; Evangelista M
Life Support Syst; 1984; 2(4):245-51. PubMed ID: 6527556
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of complement activation, cytokine liberation and beta 2 microglobulin in the use of various dialysis and hemofiltration membranes].
Falkenhagen D; Thomaneck U; Brown GS; Werner H; Klinkmann H
Z Urol Nephrol; 1989 Oct; 82(10):541-50. PubMed ID: 2692346
[TBL] [Abstract][Full Text] [Related]
14. [The effect of hemoperfusion through activated charcoal on middle molecular substances in the plasma during a long-term dialysis program].
Mydlík M; Dzúrik R; Derzsiová K; Spustová V
Cas Lek Cesk; 1983 Dec; 122(51):1573-6. PubMed ID: 6652672
[No Abstract] [Full Text] [Related]
15. Hemofiltration or hemodiafiltration with on-line production of substitution fluid: clinical observation of safety and effectiveness.
Li X; Li M; Liu T; Li L; Duan L; Li Y; Yang G; Guo L
Chin Med J (Engl); 1997 Jul; 110(7):520-5. PubMed ID: 9594209
[TBL] [Abstract][Full Text] [Related]
16. [Influence of different blood purification treatment on the serum leptin and neuropeptide Y levels in patients with chronic renal failure].
Song J; Li H; Zhang XD
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Nov; 26(11):1116-8. PubMed ID: 21322279
[TBL] [Abstract][Full Text] [Related]
17. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal.
Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S
Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596
[TBL] [Abstract][Full Text] [Related]
18. In vivo clearance and elimination of nine marker substances during hemofiltration with different membranes.
Krämer BK; Pickert A; Hohmann C; Liebich HM; Müller GA; Hablitzel M; Risler T
Int J Artif Organs; 1992 Jul; 15(7):408-12. PubMed ID: 1516991
[TBL] [Abstract][Full Text] [Related]
19. Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency.
Weiss LG; Danielson BG; Fellström B; Wikström B
Nephron; 1989; 51(3):325-9. PubMed ID: 2918944
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of beta 2-microglobulin removal with high-performance hemodiafiltration.
Kinugasa E; Akizawa T; Kitaoka T; Koshikawa S
Artif Organs; 1988 Feb; 12(1):11-5. PubMed ID: 3281635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
